AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor (IC50 :1.9 nM) . AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
Product Specifications
CAS Number
909561-15-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
477.52
Molecular Formula
C25H25F2N7O
Notes
Research use only, not for human use.
Receptor
CYP3A4|STAT6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
139907 200 µL
CTGF (Connective Tissue Growth Factor, Hypertrophic Chondrocyte-specific Protein 24, Insulin-like Growth Factor-binding Protein 8, IGF-binding Protein 8, IGFBP-8, IBP-8, CCN Family Member 2, CCN2, HCS24, IGFBP8)
Sign In for Pricing
View Details MBS7180789 Inquire
Rabbit anti-Bacillus subtilis subsp. spizizenii (strain 23059/NRRL B-14472/W23) XYLA Polyclonal Antibody
Sign In for Pricing
View Details NBP3-05952CL1 0.1 mL
Rabbit Polyclonal METTL20 Antibody [CoraFluor 1]
Sign In for Pricing
View Details 